Related Experiment Video
Updated: Nov 2, 2025

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
Published on: July 16, 2021
Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes
Maedeh Arabpour1, Amene Saghazadeh2, Nima Rezaei3
1Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Abstract:
Mesenchymal stem cells (MSCs) are multipotent cells beneficial in regenerative medicine and tissue repair. The therapeutic potential of MSCs for inflammatory diseases and conditions is partly due to secreted exosomes. Exosomes are one group of extracellular vesicles with 50-150 nm in diameter. They can carry numerous molecules and introduce them to the recipient cells to produce various biological effects. Macrophages are classified into M1 and M2 subtypes based on their activation states. M1 macrophages release pro-inflammatory factors like tumor necrosis factoralfa (TNF-α), interleukin1alfa (IL-1α), interleukin1beta (IL-1β), interleukin6 (IL-6), C-X-C motif chemokine ligand 9 (CXCL9), and C-X-C motif chemokine ligand 10 (CXCL10), while M2 macrophages secrete anti-inflammatory mediators including interleukin10 (IL-10), transforming growth factor beta (TGF-β), C-C motif chemokine ligand 1 (CCL1), C-C motif chemokine ligand 17 (CCL17), C-C motif chemokine ligand 18 (CCL18), and C-C motif chemokine ligand 22 (CCL22). This review summarizes the effect of MSC-derived exosomes in the polarization of M2 macrophages, which their anti-inflammatory and immunomodulatory properties are potentially effective in inflammation diseases and conditions such as central nervous system (CNS) diseases, autoimmune diseases, inflammatory bowel disease, cardiomyopathy, graftversushost disease, kidney, liver, lung, and skin injuries.
Insights
Mesenchymal stem cell (MSC)-derived exosomes promote M2 macrophage polarization. This process holds therapeutic potential for various inflammatory and autoimmune diseases by harnessing anti-inflammatory and immunomodulatory effects.
Area of Science:
- Regenerative Medicine
- Immunology
- Cell Biology
Background:
- Mesenchymal stem cells (MSCs) are vital in regenerative medicine due to their therapeutic potential in tissue repair.
- MSC-secreted exosomes, extracellular vesicles (50-150 nm), carry molecules that influence recipient cell functions.
- Macrophages, classified as M1 (pro-inflammatory) and M2 (anti-inflammatory), play key roles in immune responses.
Purpose of the Study:
- To review the impact of MSC-derived exosomes on macrophage polarization, specifically towards the M2 phenotype.
- To explore the therapeutic implications of MSC-derived exosomes in managing inflammatory and autoimmune conditions.
Main Methods:
- Literature review focusing on studies investigating MSC-derived exosomes and macrophage polarization.
- Analysis of molecular cargo within exosomes and their effects on macrophage subtypes.
- Synthesis of findings related to the immunomodulatory properties of M2 macrophages induced by MSC exosomes.
Main Results:
- MSC-derived exosomes effectively induce the polarization of M1 macrophages towards the M2 phenotype.
- M2 macrophages secrete anti-inflammatory mediators such as IL-10 and TGF-β.
- This polarization contributes to the therapeutic effects of MSCs in inflammatory diseases.
Conclusions:
- MSC-derived exosomes possess significant immunomodulatory capabilities, primarily through M2 macrophage polarization.
- These exosomes offer a promising therapeutic strategy for a range of inflammatory conditions, including CNS diseases, autoimmune disorders, and organ injuries.
- Further research into MSC-derived exosomes could unlock novel treatments for inflammatory diseases.
More Related Videos
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
09:20Differentiation of Monocytes into Phenotypically Distinct Macrophages After Treatment with Human Cord Blood Stem Cell CB-SC-Derived Exosomes
Published on: November 12, 2020
Related Concept Videos
Mesenchymal Stem Cells
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...